Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
World Journal of Surgery
Erschienen in: World Journal of Surgery 1/2013

01.01.2013

Therapeutic Mammaplasty for Breast Cancer: Oncological and Aesthetic Outcomes

verfasst von: Alexandra Grubnik, Carol Benn, Gereth Edwards

Erschienen in: World Journal of Surgery | Ausgabe 1/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Therapeutic mammaplasty (TM) for breast cancer is a widely practiced oncoplastic technique. Patient selection criteria and method of margin assessment are not clearly established. The aim of our review was to analyse oncological and aesthetic outcomes over a 7 year period.

Methods

We conducted a retrospective review of 251 breast cancer patients who underwent TM from 2002 to 2009 at the Netcare Breast Care Centre, Johannesburg. Primary chemotherapy was used to downsize large tumours. Intraoperative margin assessment was performed. Statistical analysis was performed using Kaplan–Meier estimates. Cosmetic outcomes were assessed by an independent review panel using photographic material.

Results

Mean tumour size was 15.4 mm. Mean resection weight was 237 g. Sixty-four (25.5 %) patients received primary chemotherapy. Mean margin taken was 15 mm. The back-to-theatre rate was 2 % (5 cases). A total of 222 patients underwent bilateral procedures. Contralateral occult disease was identified in six cases (2.4 %). The early (<2 months) complication rate was 3.2 %. Late complications were related to adjuvant radiotherapy (20.7 %). Mean follow-up was 50 months. The recurrence rate was 4 %. Five of six patients with locoregional recurrence had DCIS at initial surgery. The mortality rate was 3.2 %. The overall survival rate was 96.4 % and the metastasis-free survival rate was 94.6 %. Acceptable aesthetic results were achieved in 96 % of the patients.

Conclusions

Primary chemotherapy allowed for TM in patients with large tumours. Intraoperative margin assessment decreased reoperation rate. Contralateral matching procedures resulted in histological detection of occult disease. TM is an oncologically appropriate and cosmetically favourable technique.
Literatur
1.
Ferlay J, Shin HR, Bray F et al (2010) Estimates of worldwide burden of cancer 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917PubMedCrossRef
2.
Vorobiof D, Sitas F, Vorobiof G (2001) Breast cancer incidence in South Africa. J Clin Oncol 19:125–127
3.
Halsted WS (1894) The results of operations for cure of cancer of the breast performed at the Johns Hopkins Hospital from June 1889 to January 1894. Ann Surg 20:497PubMedCrossRef
4.
Fisher B, Anderson S, Bryant J et al (2002) Twenty-year follow-up of a randomised trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347:1233–1241PubMedCrossRef
5.
Veronesi U, Cascinelli N, Mariani L et al (2002) Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347:1227–1232PubMedCrossRef
6.
Van Dongen J, Voogd A, Fentiman I et al (2000) Long-term results of a randomised trial comparing breast-conserving therapy with mastectomy: European Organisation for Research and Treatment of Cancer 10801 Trial. J Natl Cancer Inst 92:1143PubMedCrossRef
7.
Arriagada R, Le M, Rochard F et al (1996) Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. J Clin Oncol 14:1558PubMed
8.
Jacobson J, Danforth D, Cowan K et al (1995) Ten-year results of comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med 332:907PubMedCrossRef
9.
Fisher B, Dignam J, Wolmark N et al (1998) Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 16:441–452PubMed
10.
Solin LJ, Kurtz J, Fourquet A et al (1996) Fifteen year results of breast conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 14:754–763PubMed
11.
Fisher B, Brown A, Mamounas E et al (1997) Effect of preoperative chemotherapy on local-regional disease in women with operable breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-18. J Clin Oncol 15:2483–2493PubMed
12.
Schwartz GF, Birchansky CA, Komarnicky LT et al (1994) Induction chemotherapy followed by breast conservation for locally advanced carcinoma of the breast. Cancer 73:362–369PubMedCrossRef
13.
Dewar JA, Benhamou S, Benhamou E et al (1988) Cosmetic results following lumpectomy axillary dissection and radiotherapy for small breast cancers. Radiother Oncol 12:273–280PubMedCrossRef
14.
Petit JY, Rigaut L, Zekri A et al (1989) Poor aesthetic results after conservative treatment of breast cancer. Techniques of partial breast reconstruction. Ann Chir Plast Esthet 34:103–108PubMed
15.
Sacchini V, Luini A, Tana S et al (1991) Quantitative and qualitative cosmetic evaluation after conservative treatment for breast cancer. Eur J Cancer 27:1395–1400PubMedCrossRef
16.
Amichetti M, Busana L, Caffo O (1995) Long-term cosmetic outcome and toxicity in patients treated with quadrantectomy and radiation therapy for early-stage breast cancer. Oncology 52:177–181PubMedCrossRef
17.
Rose MA, Olivotto I, Cady B et al (1989) Conservative surgery and radiation therapy for early breast cancer. Long-term cosmetic results. Arch Surg 124:153–157PubMedCrossRef
18.
Abner AL, Recht A, Vicini FA et al (1991) Cosmetic results after surgery, chemotherapy, and radiation therapy for early breast cancer. Int J Radiat Oncol Biol Phys 21:331–338PubMedCrossRef
19.
Moro G, Ciambellotti E (1993) Evaluation of the esthetic results of conservative treatment of breast cancer. Tumori 79:258–261PubMed
20.
Clough K, Cuminet J, Fitoussi A et al (1998) Cosmetic sequelae after conservative treatment for breast cancer: classification and results of surgical correction. Ann Plast Surg 41:471–481PubMedCrossRef
21.
Clough KB, Lewis JS, Couturaud B et al (2003) Oncoplastic techniques allow extensive resections for breast-conserving therapy of breast carcinomas. Ann Surg 237:26–34PubMedCrossRef
22.
Audretsch W, Rezai M, Kolotas C et al (1998) Tumor-specific immediate reconstruction in breast cancer patients. Perspect Plast Surg 11:71–100
23.
Clough K, Thomas S, Fitoussi A et al (2004) Reconstruction after conservative treatment for breast cancer: cosmetic sequelae classification revisited. Plast Reconstr Surg 114:1743PubMedCrossRef
24.
Rietjens M, Petit JY, Contesso G et al (1997) The role of reduction mammaplasty in oncology. Eur J Plast Surg 20:246–250CrossRef
25.
Waljee J, Hu E, Ubel P et al (2008) Effect of esthetic outcome after breast-conserving surgery on psychosocial functioning and quality of life. J Clin Oncol 26:3331PubMedCrossRef
26.
Keith D, Walker M, Walker L et al (2003) Women who wish breast reconstruction: characteristics, fears, and hopes. Plast Reconstr Surg 111:1051–1056PubMedCrossRef
27.
Al-Ghazal SK, Fallowfield L, Blamey RW (2000) Comparison of psychological aspects and patient satisfaction following breast conserving surgery, simple mastectomy and breast reconstruction. Eur J Cancer 36:1938–1943PubMedCrossRef
28.
Rowland JH, Desmond KA, Meyerowitz BE et al (2000) Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst 92:1422–1429PubMedCrossRef
29.
Kaur N, Petit JY, Rietjens M et al (2005) Comparative study of surgical margins in oncoplastic surgery and quadrantectomy in breast cancer. Ann Surg Oncol 12:1–7CrossRef
30.
Petit JY, Rietjens M, Contesso G et al (1997) Contralateral mastoplasty for breast reconstruction: a good opportunity for glandular exploration and occult carcinomas diagnosis. Ann Surg Oncol 4:511–515PubMedCrossRef
31.
Losken A, Elwood E, Styblo T et al (2002) The role of reduction mammaplasty in reconstructing partial mastectomy defects. Plast Reconstr Surg 109:968PubMedCrossRef
32.
Petit JY, Garusi C, Greuse M et al (2002) One hundred and eleven cases of breast conservation treatment with simultaneous reconstruction at the European Institute of Oncology (Milan). Tumori 88:41–47PubMed
33.
Brierley J, Paterson I, Lallemand R et al (1991) The influence of breast size on late radiation reaction following excision and radiotherapy for early breast cancer. Clin Oncol 3:6–9CrossRef
34.
Gray JR, McCormick B, Cox L et al (1991) Primary breast irradiation in large-breasted or heavy women: analysis of cosmetic outcome. Int J Radiat Oncol Biol Phys 21:347–354PubMedCrossRef
35.
Moody AM, Mayles WP, Bliss JM et al (1994) The influence of breast size on late radiation effects and association with radiotherapy dose inhomogeneity. Radiother Oncol 33:106–112PubMedCrossRef
36.
Zierhut D, Flentje M, Frank C et al (1994) Conservative treatment of breast cancer: modified irradiation technique for women with large breasts. Radiother Oncol 31:256PubMedCrossRef
37.
Clarke D, Martinez A, Cox R (1983) Analysis of cosmetic results and complications in patients with stage I and II breast cancer treated by biopsy and irradiation. Int J Radiat Oncol Biol Phys 9:1807–1813PubMedCrossRef
38.
Ray GR, Fish VJ (1983) Biopsy and definitive radiation in stage I and II adenocarcinoma of the female breast: analysis of cosmesis and the role of electron beam supplementation. Int J Radiat Oncol Biol Phys 9:813–818PubMedCrossRef
39.
Losken A, Hamdi M (2009) Partial breast reconstruction: current perspectives. Plast Reconstr Surg 124:722PubMedCrossRef
40.
Spear S, Pelletiere C, Wolfe A et al (2003) Experience with reduction mammaplasty combined with breast conservation therapy in the treatment of breast cancer. Plast Reconstr Surg 111:1102PubMedCrossRef
41.
Clough K, O’Donoghue J, Fitoussi A et al (2001) Prospective evaluation of late cosmetic results following breast reconstruction: I. Implant reconstruction. Plast Reconstr Surg 107:1702PubMedCrossRef
42.
Khatcheressian JL, Wolff AC, Smith TJ et al (2006) American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guideline in the adjuvant setting. J Clin Oncol 24:5081–5097
43.
Lyman GH, Giuliano AE, Somerfield MR et al (2005) American society of clinical oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol 23:7703–7720PubMedCrossRef
44.
Carlson RW, Allred DC, Anderson BO et al (2009) Breast Cancer. Clinical practice guidelines in oncology. J Natl Compr Canc Netw 7:122–192PubMed
45.
Schwartz G, Veronesi U, Clough K et al (2005) Consensus conference on breast conservation, Milan, Italy, April 28–May 1, 2005. Breast J 12:398–407CrossRef
46.
47.
Miltenburg DM, Miller C, Karamlou TB et al (1999) Meta-analysis of sentinel lymph node biopsy in breast cancer. J Surg Res 84:138–142PubMedCrossRef
48.
Edge SB, Byrd DR, Compton CC (2910) AJCC cancer staging handbook: from the AJCC cancer staging manual. Springer, New York
49.
Clough K, Nos C, Salmon RJ et al (1995) Conservative treatment of breast cancers by mammaplasty and irradiation: a new approach to lower quadrant tumours. Plast Reconstr Surg 96(2):363–370PubMedCrossRef
50.
Sabel MS (2011) Surgical considerations in early-stage breast cancer: lessons learned and future directions. Semin Radiat Oncol 21:10–19PubMedCrossRef
51.
Regano S, Hernanz F, Ortega E et al (2009) Oncoplastic techniques extend breast-conserving surgery to patients with neoadjuvant chemotherapy response unfit for conventional techniques. World J Surg 33:2082–2086. doi:10.​1007/​s00268-009-0152-x PubMedCrossRef
52.
Luu HH, Otis CN, Reed WP et al (1999) The unsatisfactory margin in breast cancer surgery. Am J Surg 178:362–366PubMedCrossRef
53.
McCulley S, Macmillan R (2005) Therapeutic mammaplasty—analysis of 50 consecutive cases. Br J Plast Surg 58:902–907PubMedCrossRef
54.
Losken A, Styblo T, Carlson G et al (2007) Management algorithm and outcome evaluation of partial mastectomy defects treated using reduction or mastopexy techniques. Ann Plast Surg 59:235PubMedCrossRef
55.
Rietjens M, Urban C, Rey P et al (2007) Long-term oncological results of breast conservative treatment with oncoplastic surgery. Breast 16:387–395PubMedCrossRef
56.
Nos C, Fitoussi A, Bourgeois D et al (1998) Conservative treatment of lower pole breast cancers by bilateral mammoplasty and radiotherapy. Eur J Surg Oncol 24:508–514PubMedCrossRef
57.
Meretoja TJ, Svarvar CS, Jahkola TA (2010) Outcome of oncoplastic breast surgery in 90 prospective patients. Am J Surg 200:224–228PubMedCrossRef
58.
Fitoussi AD, Berry MG, Fama F et al (2010) Oncoplastic breast surgery for cancer: analysis of 540 consecutive cases. Plast Reconstr Surg 125:454PubMedCrossRef
59.
Ramanah R, Pivot X, Sautiere JL et al (2008) Predictors of re-excision for positive or close margins in breast-conservation therapy for pT1 tumours. Am J Surg 195:770–774PubMedCrossRef
60.
Schnitt SJ, Abner A, Gelman R et al (1994) The relationship between microscopic margins of resection and the risk of local recurrence in patients treated with breast conserving surgery and radiation therapy. Cancer 74:1746–1751PubMedCrossRef
61.
Meric F, Mirza NQ, Vlastos G (2003) Positive surgical margins and ipsilateral breast tumour recurrence predicts disease-specific survival after breast conserving therapy. Cancer 97:926–933PubMedCrossRef
62.
Cothier-Savey I, Otmezguine Y, Calitchi E et al (1996) Value of reduction mammoplasty in the conservative treatment of breast neoplasms. Apropos of 70 cases. Ann Chir Plast Esthet 41:346–353PubMed
63.
Bonadonna G, Veronesi U, Brambilla C et al (1990) Primary chemotherapy to avoid mastectomy in tumours with diameters of three centimetres or more. J Natl Cancer Inst 82:1539–1545PubMedCrossRef
Metadaten
Titel
Therapeutic Mammaplasty for Breast Cancer: Oncological and Aesthetic Outcomes
verfasst von
Alexandra Grubnik
Carol Benn
Gereth Edwards
Publikationsdatum
01.01.2013
Verlag
Springer-Verlag
Erschienen in
World Journal of Surgery / Ausgabe 1/2013
Print ISSN: 0364-2313
Elektronische ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-012-1786-7

Weitere Artikel der Ausgabe 1/2013

World Journal of Surgery 1/2013 Zur Ausgabe

OriginalPaper

Relationship between Preoperative Volume and Weight of the Right Liver Lobe Graft, with and without the Middle Hepatic Vein, in Living-Donor Transplantation

OriginalPaper

Elevated Preoperative Carcinoembryonic Antigen (CEA) and Ki67 Is Predictor of Decreased Survival in IIA Stage Colon Cancer

OriginalPaper

Incidence and Localization of Ectopic Parathyroid Adenomas in Previously Unexplored Patients

ReviewPaper

Role of Laparoscopy in Penetrating Abdominal Trauma: A Systematic Review

OriginalPaper

A Randomized, Double-blinded Placebo-controlled Clinical Trial of the Routine Use of Preoperative Antibiotic Prophylaxis in Modified Radical Mastectomy

OriginalPaper

Preoperative Assessment of Tumor Location and Station-Specific Lymph Node Status in Patients with Adenocarcinoma of the Gastroesophageal Junction

Neu im Fachgebiet Chirurgie

23.04.2024 | Ablationstherapie | Nachrichten

Wie erfolgreich ist eine Re-Ablation nach Rezidiv?

23.04.2024 | Appendizitis | Nachrichten

Hinter dieser Appendizitis steckte ein Erreger

23.04.2024 | Operationsvorbereitung | Nachrichten

Mehr Schaden als Nutzen durch präoperatives Aussetzen von GLP-1-Agonisten?

19.04.2024 | EAU 2024 | Kongressbericht | Nachrichten

Ureterstriktur: Innovative OP-Technik bewährt sich
weitere anzeigen

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.